Skip to Main Content
Our Commitment to Diversity

K&L Gates Triage: Q&A: What Sponsors and Investigators Need to Know about FDA's ClinicalTrials.gov Reporting Requirements

Date: 27 August 2020

FDA’s recent release of new guidance on civil money penalties for the failure to submit required information to the ClinicalTrials.gov data bank may indicate a renewed interest in the enforcement of these requirements. On this week’s episode, Lindsey Rogers-Seitz and Kenneth Kennedy discuss the scope of FDA’s clinicaltrials.gov reporting requirements, as well as the penalties responsible parties may face for failing to meet them.

Lindsey T. Rogers-Seitz
Lindsey T. Rogers-Seitz
Research Triangle Park
View
Kenneth M. Kennedy
Kenneth M. Kennedy
Research Triangle Park
View
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel